Cosmos Health Inc. (COSM) Stock Price, Financial Report, & Fundamental AnalysisNASDAQ:COSM
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company.
Cosmos Health Inc. Fundamental Analysis
COSM has had growing revenue for the last 5 years
Price to Book (PBV) Ratio
Undervalued price-to-book. COSM stock price is under 1x the price-to-book value.
COSM has positive revenue for last 5 years
Small market capitalization. Market capitalization is less than 2bn USD
Net Income Growth
COSM has never had growing net income.
COSM never has positive net income for 2 years.
Debt-Equity Ratio (DER)
COSM debt is 7.85x it's equity.
COSM has low dividend yield (0%).
Return of Assets
COSM has low return of asset (-63.87%).
Return of Equity
COSM has low return of equity (-510.29%).
Return of Invested Capital
COSM has low ROIC.
Cosmos Health Inc. Financials
Financial statements are written records that convey the business activities and the financial performance of a company. Financial statements include the balance sheet, income statement, and statement of cash flow.
Also known as the profit and loss (P&L) statement or the statement of revenue and expense, the income statement primarily focuses on the company’s revenue and expenses during a particular period.
- 56,239,667 USD
- 60,773,071 USD
- Net Income
- -15,594,682 USD
- Profit Margin
A cash flow statement is a financial statement that provides aggregate data regarding all cash inflows a company receives from its ongoing operations and external investment sources. It also includes all cash outflows that pay for business activities and investments during a given period.
- Free Cash Flow
- -7,678,572 USD
Liquidity & Solvency
Solvency refers to an company's capacity to meet its long-term financial commitments. Liquidity refers to an company's ability to pay short-term obligations. The term also refers to a company's capability to sell assets quickly to raise cash.
Short Term Liabilities
Long Term Liabilities
|Dividend Payout Ratio (DPR)||0%|
|Dividend Payout Ratio (DPR)||0%|
|Dividend per Share||0,00 USD|
|Price to Earning (PER)||-4.1x|
|Price to Earning-Growth (PEG)||0x|
|Price to Book Value (PBV)||0x|
|Debt-Equity Ratio (DER)||784.84%|
|Net Profit Margin (NPM)||-53.49%|
|Return of Assets (ROA)||-63.87%|
|Return of Equity (ROE)||-510.29%|
|Return on Capital Employed (ROCE)||-7.89%|
|Days of Sales Outstanding (DSO)||184.86|
|Days of Inventory Outstanding (DIO)||31.6|
|Days Payable Outstanding (DPO)||90.51|
|Operating Cycle (OC)||77.18|
|Cash Conversion Cycle (CCC)||102.14|
Cosmos Health Inc. Executives
- CEO Name
- Mr. Grigorios Siokas
Cosmos Health Inc. Profile
About Cosmos Health Inc.
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
- Company name
- Cosmos Health Inc.
- NASDAQ Capital Market
- Drug Manufacturers—Specialty & Generic
141 West Jackson Boulevard